A federal judge refused to block generic rosuvastatin (Crestor), turning down drugmaker AstraZeneca's suit seeking 7 more years of exclusivity.
Another wave of marketing for heart failure drug Entresto is set to drag down profit at drugmaker Novartis.
A surgeon's degree of specialization in carotid endarterectomy, CABG, valve replacement, and abdominal aortic aneurysm repair was an important predictor of operative mortality independent of volume for each procedure, a Medicare data analysis found.
Salt sensitivity: It's complicated. That was the gist of a statement from the American Heart Association. See the more extensive summary here.
Heparin started within 72 hours of traumatic brain injury protected against deep vein thrombosis and pulmonary embolism without raising bleeding complications or mortality, an American College of Surgeons database study found.
The "don't eat me" signal tumor cells use to ward off immune system attacks also may play a role in atherosclerosis, a study suggested.
When stentriever fail to restore flow in anterior circulation large artery ischemic stroke, permanent stenting could be a rescue strategy, South Korean researchers reported.
There's an "urgent" need for qualitative and quantitative NOAC assays, two thrombosis specialists argued.
An observational head-to-head comparison of the new oral anticoagulants (NOACs) against each other and warfarin (Coumadin) for longer-term treatment of first-time venous thromboembolic events is being funded by the Patient-Centered Outcomes Research Institute.
The FDA cleared the Celt ADC vascular closure device for closing arterial punctures.
The FDA warned Oscor about good manufacturing practice violations for its introducer catheters.
Angiodynamics' Soft Vu Omni Flush Angiographic Catheter for contrast dye injection has a Class I recall over reports of separation of the catheter tip from the main body of the device.
European regulators approved two biosimilar versions of enoxaparin (Lovenox) with the brand names Thoriane and Inhixa for treating blood clots.
Homozygous familial hypercholesterolemia drug lomitapide (Juxtapid) will be pulled from the European market over slow sales but will remain on U.S. pharmacy shelves.
Canada cleared the bioresorbable Absorb cardiac stent.
India put all coronary stents on its national list of essential medicines, which is expected to mean price controls.
CardioBreak is a guide to what's new and interesting on the Web for cardiologists and other healthcare professionals with an interest in cardiovascular disease, powered by the MedPage Today community. Got a tip? Send it to us: c.phend@medpagetoday.com.
CardioBreak: Generic Crestor; Specialization Saves Lives; Catheter Recall
Aucun commentaire:
Enregistrer un commentaire